Advertisement

Topics

Alexis Biochemical Company Profile

08:05 EDT 25th March 2019 | BioPortfolio

ALEXIS, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents.

These reagents product lines have included:



Apoptosis

Cell Cycle & DNA Transactions

Growth Factors, Cytokines & Chemokines

Immunology & Cancer Research

Neurochemicals

Nitric Oxide & Oxidative Stress

Signal Transduction & Cell Trafficking



Over the years ALEXIS Corporation has developed a substantial global marketing and sales organization, with four wholly owned sales offices (in US, Switzerland, Germany, and UK), one operational center (in Switzerland), three branch offices (in Italy, Japan and Korea) and 17 partner companies covering all major markets.

Location

6181 Cornerstone Court EastSuites 102-104
San Diego
CA
92121-4727
United States of America

Contact

Phone: 619 658 0065
Fax: 619 658 9224


News Articles [101 Associated News Articles listed on BioPortfolio]

SIOP recognizes Alexis Fink for service to the Society

(Society for Industrial and Organizational Psychology) The Society for Industrial and Organizational Psychology has honored Alexis Fink, PhD, for her sustained, significant, and outstanding service to...

Recognition for biotechnology influencer

(University of Delaware) As the director of NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals, Kelvin Lee is a changemaker in the biomanufacturing industry. He will rec...

Biochemical Recurrence Predicts Prostate-Cancer Survival in Some

Biochemical recurrence predicts survival in men with prostate cancer who have additional specific clinical risk factors, according to a systematic review. Reuters Health Information

Time to biochemical failure could be used as surrogate endpoint in treatment: LA prostate cancer

(NRG Oncology) An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure (IBF), or the time it takes for previously treated cancer to return ...

OSE Immunotherapeutics to Present at Biotech Showcase 2019 Conference

During JP Morgan Healthcare ConferenceSan Francisco, January 7-9, 2019 Regulatory News: OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) (Paris:OSE), today announced that Alexis Peyroles, C...

Patient Education Can Improve Chronic Disease Management

FRIDAY, Dec. 7, 2018 -- An educational intervention can improve patients' ability to self-manage their chronic diseases, according to a study published in the November issue of the Journal of the Amer...

Stress at work

Stress is one of the leading causes of work absence, recently overtaking back-pain, and an increasing part of a GPs workload. However good quality evidence about how to deal with stress is hard to com...

Accessing analytes in biofluids for peripheral biochemical monitoring

PubMed Articles [364 Associated PubMed Articles listed on BioPortfolio]

Characterisation of barley resistance to rhynchosporium on chromosome 6HS.

Major resistance gene to rhynchosporium, Rrs18, maps close to the telomere on the short arm of chromosome 6H in barley. Rhynchosporium or barley scald caused by a fungal pathogen Rhynchosporium commun...

Overview of Biochemical Assays in Lipidic Cubic Phase.

The development of novel biochemical methods to efficiently characterize membrane protein (MP) properties in lipidic cubic phase (LCP) is important for studying complicated MPs and their multimeric co...

Associations between executive function impairment and biochemical abnormalities in bipolar disorder with suicidal ideation.

Executive dysfunction and biochemical abnormalities using proton magnetic resonance spectroscopy (H-MRS) have been reported in bipolar disorder (BD). Much less is known about the information from BD w...

Final products and kinetics of biochemical and chemical sulfide oxidation under microaerobic conditions.

Hydrogen sulfide is a toxic and usually undesirable by-product of the anaerobic treatment of sulfate-containing wastewater. It can be removed through microaeration, a simple and cost-effective method ...

Biochemical Markers, Genotype, and Inflammation in Pediatric Inflammatory Bowel Disease: A Danish Population-Based Study.

Our aim was to characterize the biochemical markers at diagnosis in patients with inflammatory bowel disease (IBD), to assess the utility of these to predict disease course and investigate if genotype...

Clinical Trials [811 Associated Clinical Trials listed on BioPortfolio]

Alexis O-Ring Wound Retractor for the Prevention of Post-cesarean Surgical Site Infections

Post cesarean section surgical site infection (SSI) is a common complication that can affect patient recovery and overall outcome. Several approaches have been studied to improve SSI rates...

Wound Infection Alexis Wound Retractor

The purpose of this study is to determine whether the incidence of surgical site wound infection will be reduced in open appendectomy patients through the use of the Alexis® wound retract...

Surgical Site Infection in Caesarean Section Using Alexis O Compared to Metal Retractors

Objective: To investigate if the use of the newly designed Alexis O Retractor leads to improved intra-operative and post-operative surgical outcomes in the setting of planned elective ...

Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy

Surgical site infection (SSI) is a leading cause of preventable morbidity and mortality in North America and worldwide. This condition has consistently been reported to account for up to 2...

Effects of Cox-II Inhibitor on Biochemical Markers in Cardiovascular-related Adverse Effects

The selective cyclooxygenase-2 (COX-2) inhibitors have been associated with increased cardiovascular risk. The goal of the present study is to investigate the impacts of COX-2 inhibitors ...

Companies [145 Associated Companies listed on BioPortfolio]

Alexis Biochemical

ALEXIS, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents. These reagents product lines have included: Apoptosis Cell Cycle & DNA Transactions Growth Facto...

Alexis Corporation

ALEXIS Corporation, founded in 1993/94, is a worldwide operating producer and distributor of life science reagents. These reagents product lines have included: Apoptosis Cell Cycle & DNA Transactions ...

Stallergenes

For 50 years, Stallergenes specialist treatment of severe respiratory allergies by allergen immunotherapy, has set itself the objective, alongside health professionals to advance the treatment of se...

EY Laboratories Incorporated

Manufacturer of biochemical reagents serving the needs of biochemical research in glycobiology, immunology, and microbiology. Manufacturer of rapid, simple, and stable diagnostic test kits for visual ...

Gadot Biochemical Industries Ltd.

Gadot Biochemical Industries Ltd. is a leading manufacturer of ingredients and fine chemicals for the food & beverage, cosmetic, detergent and pharmaceutical industries.

More Information about "Alexis Biochemical" on BioPortfolio

We have published hundreds of Alexis Biochemical news stories on BioPortfolio along with dozens of Alexis Biochemical Clinical Trials and PubMed Articles about Alexis Biochemical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alexis Biochemical Companies in our database. You can also find out about relevant Alexis Biochemical Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record